HC2 Holdings Reports Second Quarter 2017 Results


NEW YORK, Aug. 09, 2017 (GLOBE NEWSWIRE) -- HC2 Holdings, Inc. (“HC2”) (NYSE:HCHC), a diversified holding company, announced today its consolidated results for the second quarter 2017, which ended on June 30, 2017.

"During the second quarter, we continued the momentum with which we began the year," said Philip Falcone, HC2's Chairman, President and Chief Executive Officer.  "DBM Global maintained a healthy backlog, expects to remain on-track for a solid year, and is well-positioned to capitalize on several large opportunities ahead.  Global Marine also remained on track for a solid year, reflecting the strength of its joint venture with Huawei Marine and a high-level of fleet activity supporting maintenance zone agreements around the world, and/or installation, maintenance or repair contracts across the offshore power and telecom sectors.  American Natural Gas continues to expand its nationwide network of compressed natural gas fueling stations with the opening of new stations in Fayetteville, Tennessee, for which PepsiCo's Frito-Lay division will be a major customer, and in Liverpool, New York, to meet demand for high-performing, easily-accessible CNG fueling facilities for the Northeast region's heavy-duty and long-haul trucking fleets.  In addition, during the second quarter, two of our Pansend Life Sciences companies again achieved important strategic milestones with R2 Dermatology receiving FDA approval for the second generation R2 Dermal Cooling System, and BeneVir Biopharm, which is focused on developing oncolytic immunotherapies for the treatment of cancer, receiving a key patent that further strengthens its product development program."

Mr. Falcone, continued, “At the corporate level, we completed the transfer of our common stock listing to the prestigious New York Stock Exchange, continued to focus on further reducing the cumulative outstanding amount of our Preferred Stock, and, through a private placement, we issued $38.0 million aggregate principal amount of 11.000% Senior Secured Notes.  Near the end of the quarter, we further expanded our diverse platform of investments with the announcement of an agreement to acquire a majority interest in DTV America, a nationwide low power television distribution network, which we believe is poised to capitalize on a number of compelling opportunities.  Our solid second quarter and year-to-date results, significant portfolio company milestones, and the steps we've taken at the corporate level, should help us continue to drive performance and generate long-term shareholder value during the second half of the year and beyond."

Second Quarter & Year-To-Date Financial Highlights

  • Net Revenue: For the second quarter of 2017, HC2 recorded consolidated total net revenue of $378.7 million, as compared to $359.3 million for the year-ago quarter.  The $19.4 million or 5.4% year-over-year increase was driven primarily by growth in the Construction, Marine Services, Energy and Insurance segments.  For the first six months of 2017, HC2 recorded consolidated total net revenue of $769.2 million, as compared to $691.0 million for the 2016 comparable period, driven by increases in revenue across all reporting segments.
                   
  • Net Income / (Loss): For the second quarter of 2017, HC2 reported a Net (Loss) attributable to common and participating preferred stockholders of $(18.7) million or $(0.44) per fully diluted share, as compared to Income of $0.9 million or $0.02 per fully diluted share for the second quarter 2016.  For the first six months of 2017, HC2 reported a Net (Loss) attributable to common and participating preferred stockholders of $(33.8) million or $(0.80) per fully diluted share, as compared to a (Loss) of $(30.6) million or $(0.87) per fully diluted share in the 2016 comparable period.

  • Adjusted EBITDA: Adjusted EBITDA for “Core Operating Subsidiaries,” which includes HC2's Construction, Marine Services, Energy and Telecom segments, was a combined $17.9 million for the second quarter of 2017, as compared to $27.1 million for the year-ago quarter.  For the first six months of 2017, Adjusted EBITDA for "Core Operating Subsidiaries" was $45.7 million, as compared to $39.8 million for the 2016 comparable period, driven primarily by Marine Services, Telecom, and Energy segments.

    For the second quarter of 2017, Total Adjusted EBITDA (excluding the Insurance segment), which includes results from Core Operating Subsidiaries, Early-Stage and Other, and Non-operating Corporate segments, was $4.6 million, as compared to $15.2 million for the year-ago quarter.  For the first six months of 2017, Total Adjusted EBITDA (excluding the Insurance segment), was $21.3 million, as compared to $15.5 million for the 2016 comparable period, driven primarily by Marine Services, Telecom and Energy segments, as well as a net decrease in reported net losses associated with Other segment investments.
  • Balance Sheet: As of June 30, 2017, HC2 had consolidated cash, cash equivalents and investments of $1.7 billion, which includes cash and investments associated with HC2's Insurance segment.  Excluding the Insurance segment, consolidated cash was $104.6 million, of which $56.0 million was at the HC2 corporate level.

Second Quarter & Year-to-Date Segment Highlights

  • Construction - For the second quarter of 2017, HC2’s DBM Global, reported Net Income of $4.2 million, as compared to $9.4 million for the year-ago quarter.  For the six months of 2017, Net Income was $7.4 million, as compared to $13.7 million for the 2016 comparable period.  Adjusted EBITDA was $11.1 million for the second quarter, as compared to $13.2 million for the year-ago quarter, due in part to better-than-bid performance on commercial projects in the West region recognized in the year-ago quarter.  For the first six months of 2017, DBM Global's Adjusted EBITDA was $19.7 million, as compared to $24.7 million in the 2016 comparable period, due primarily to timing associated with design changes on certain existing projects in backlog and better-than bid performance on two large commercial projects in the second quarter 2016.

    Backlog at the end of the second quarter was $590 million, as compared to approximately $498 million in the prior-quarter and $344 million in the year-ago second quarter.  Taking into consideration awarded, but not yet signed contracts, backlog would have been over $800 million.  DBM Global continues to see a number of large opportunities in the commercial sector totaling approximately $400 million in potential new projects that could be awarded over the next several quarters.  These projects include new sporting arenas or stadiums, as well as new healthcare facilities, commercial office buildings and convention centers.

  • Marine Services - For the second quarter of 2017, Global Marine reported a Net (Loss) of $(3.1) million, as compared to a Net Income of $6.0 million for the year-ago quarter.  For the first six months of 2017, Net Income was $8.1 million, as compared to $0.1 million for the 2016 comparable period.  Adjusted EBITDA was $3.6 million for the second quarter, as compared to $11.8 million for the year-ago quarter, due primarily to higher costs associated with two offshore power installation and repair projects in the second quarter of 2017, which Global Marine expects to partially recover in the second half of 2017, coupled with strong income associated with Global Marine's joint venture with Huawei Marine in the year-ago second quarter.  For the first six months of 2017, Global Marine's Adjusted EBITDA was $20.0 million, as compared to $12.3 million in the 2016 comparable period, due primarily to higher joint venture income from Huawei Marine.

  • Energy - For the second quarter of 2017, American Natural Gas (ANG) reported a Net (Loss) of $(0.4) million, as compared to a Net Income of $0.1 million for the year-ago quarter.  For the first six months of 2017, Net (Loss) was $(1.1) million, as compared to Net Income of $0.04 million for the 2016 comparable period.  Adjusted EBITDA was $1.0 million for the second quarter, as compared to $0.5 million for the year-ago quarter, driven primarily by an increase in the number of fueling stations owned and/or operated.   For the first six months of 2017, ANG's Adjusted EBITDA was $2.2 million, as compared to $0.9 million in the 2016 comparable period.  ANG continues to own and/or operate approximately 40 natural gas fueling stations, including stations under development, in 15 states and is focused on increasing volumes at existing stations while also expanding the geographic footprint through both internal / organic growth and strategic M&A transactions.

  • Telecommunications - For the second quarter of 2017, PTGi-ICS reported Net Income of $2.1 million, as compared to $1.0 million for the year-ago quarter.  For the first six months of 2017, Net Income was $3.6 million, as compared to $2.2 million for the 2016 comparable period.  Adjusted EBITDA was $2.2 million for the second quarter, as compared to $1.5 million for the year-ago quarter, driven primarily by continued focus on higher margin wholesale traffic mix and improved operational efficiencies and customer relationships across the platform.  For the first six months of 2017, PTGi-ICS's Adjusted EBITDA was $3.8 million, as compared to $1.8 million in the 2016 comparable period.

  • Insurance - As of June 30, 2017, Continental Insurance Group had approximately $69 million of statutory surplus, $79 million of total adjusted capital and $2.1 billion in total GAAP assets.

  • Pansend Life Sciences - Companies in the Pansend portfolio continued to achieve key strategic milestones during the second quarter, including R2 Dermatology, which received notification from the United States Food and Drug Administration of market clearance of R2 Dermatology's second generation device, the R2 Dermal Cooling System.  The R2 Dermal Cooling System is intended for use in dermatologic procedures for the removal of benign lesions of the skin, including skin lightening and skin evening.  Modifications to the initial R2 device were implemented to improve usability of the device, e.g., to reduce the steps required by the user for set up of the system and treatment, and to make it more commercially appealing.

    In addition, BeneVir Biopharm, Inc., a biotechnology company developing oncolytic immunotherapies for the treatment of cancer, announced during the second quarter that the U.S. Patent and Trademark Office had issued US Patent No. 9,623,059, entitled “Oncolytic Herpes Simplex Virus and Therapeutic Uses Thereof,” covering the composition of matter for Stealth-1H, BeneVir’s lead oncolytic immunotherapy, as well as other platform assets.  This patent further strengthens BeneVir’s product development program and protects its product platform through 2032.  BeneVir plans to bring Stealth-1H into the clinic next year and accelerate the pre-clinical development of its platform assets to help a diverse array of patients whose tumors do not respond to current therapeutic options, including immune checkpoint inhibitors.

  • HC2 Corporate - During the second quarter of 2017, the Company completed a private placement of $38.0 million aggregate principal amount of 11.000% Senior Secured Notes due 2019 (the "Notes") to investment funds affiliated with three institutional investors.  The Company expects to use the net proceeds from the issuance of the Notes for working capital for the Company and its subsidiaries, for general corporate purposes, as well as the financing of acquisitions and investments.  The Notes were issued at an issue price of 101.000%, plus accrued interest from June 1, 2017.

    In addition, the Company announced that a subsidiary of HC2 Holdings entered into a series of transactions that, if certain conditions are met and approval by the Federal Communications Commission is received, will result in HC2 and its subsidiaries owning over 50% of shares of common stock of DTV America Corporation ("DTVA").  DTVA is an aggregator and operator of low power television ("LPTV") licenses and stations across the United States.  DTVA currently owns and operates 52 LPTV stations in more than 40 U.S. cities.

    During the second quarter, the Company received approximately $11.5 million in dividends and tax share from DBM Global and PTGi-ICS, and further reduced the cumulative outstanding accreted value of the Company's Convertible Participating Preferred Stock to approximately $26.7 million from $30.0 million at the end of the first quarter 2017.  Since the end of September 2014, on a gross basis, the Company has reduced over $73 million in debt and pension liabilities at the subsidiary level.  Over the same period, the Company has reduced $28.5 million in Preferred Stock issued at the corporate level.

    Also during the second quarter, the Company completed the transfer of its common stock listing to the New York Stock Exchange from the NYSE MKT, effective May 16, 2017, remaining under the ticker symbol 'HCHC'. The transfer to one of the world's most prestigious stock exchanges marked a major milestone for the Company and aligned HC2 with some of the best companies and most influential brands in the world.

Conference Call

HC2 Holdings, Inc. will host a live conference call to discuss its second quarter 2017 financial results and operations today, Wednesday, August 9, 2017, at 5:00 p.m. ET.

Dial-in instructions for the conference call and the replay are as follows:

Live Call

Dial-In (Toll Free): 1-866-395-3893

International Dial-In: 1-678-509-7540

Participant Entry Number: 54309287

Alternatively, a live webcast of the conference call can be accessed by interested parties through the Investor Relations section of the HC2 Website, www.HC2.com.

Conference Replay*

Domestic Dial-In (Toll Free): 1-855-859-2056

International Dial-In: 1-404-537-3406

Conference Number: 54309287

*Available approximately two hours after the end of the conference call through September 8, 2017.

About HC2

HC2 Holdings, Inc. is a publicly traded (NYSE:HCHC) diversified holding company, which seeks opportunities to acquire and grow businesses that can generate long-term sustainable free cash flow and attractive returns in order to maximize value for all stakeholders.  HC2 has a diverse array of operating subsidiaries across seven reportable segments, including Construction, Marine Services, Energy, Telecommunications, Life Sciences, Insurance and Other.  HC2's largest operating subsidiaries include DBM Global Inc., a family of companies providing fully integrated structural and steel construction services, and Global Marine Systems Limited, a leading provider of engineering and underwater services on submarine cables. Founded in 1994, HC2 is headquartered in New York, New York.  Learn more about HC2 and its portfolio companies at www.hc2.com.

For information on HC2 Holdings, Inc., please contact Andrew G. Backman - Managing Director - Investor Relations & Public Relations - abackman@hc2.com - 212-339-5836.

Non-GAAP Financial Measures

In this release, HC2 refers to certain financial measures that are not presented in accordance with U.S. generally accepted accounting principles (“GAAP”), including Core Operating Subsidiary Adjusted EBITDA, Total Adjusted EBITDA (excluding the Insurance segment) and Adjusted EBITDA for its operating segments.  Management believes that Adjusted EBITDA measures provide investors with meaningful information for gaining an understanding of the Company’s results as it is frequently used by the financial community to provide insight into an organization’s operating trends and facilitates comparisons between peer companies, because interest, taxes, depreciation, amortization and the other items for which adjustments are made as noted in the definition of Adjusted EBITDA below can differ greatly between organizations as a result of differing capital structures and tax strategies. In addition, management uses Adjusted EBITDA measures in evaluating certain of the Company’s segments performance because they eliminate the effects of considerable amounts of non-cash depreciation and amortization and items not within the control of the Company’s operations managers. While management believes that these non-GAAP measurements are useful as supplemental information, such adjusted results are not intended to replace our GAAP financial results and should be read together with HC2’s results reported under GAAP.

Management defines Adjusted EBITDA as net income (loss) adjusted to exclude the impact of depreciation and amortization; amortization of equity method fair value adjustments at acquisition; (gain) loss on sale or disposal of assets; lease termination costs; asset impairment expense; loss on early extinguishment or restructuring of debt; interest expense; gain (loss) on contingent consideration; other income (expense), net; foreign currency transaction gain (loss) included in cost of revenue; income tax (benefit) expense; gain (loss) from discontinued operations; non-controlling interest; bonus to be settled in equity; share-based compensation expense and acquisition and non-recurring items. A reconciliation of Adjusted EBITDA to Net Income (Loss) is included in the financial tables at the end of this release.

Management recognizes that using Adjusted EBITDA as a performance measure has inherent limitations as an analytical tool as compared to net income (loss) or other GAAP financial measures, as these non-GAAP measures exclude certain items, including items that are recurring in nature, which may be meaningful to investors.

As a result of the exclusions, Adjusted EBITDA should not be considered in isolation and do not purport to be alternatives to net income (loss) or other GAAP financial measures as a measure of our operating performance.

Cautionary Statement Regarding Forward-Looking Statements

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This release contains, and certain oral statements made by our representatives from time to time may contain, forward-looking statements. Generally, forward-looking statements include information describing actions, events, results, strategies and expectations and are generally identifiable by use of the words “believes,” “expects,” “intends,” “anticipates,” “plans,” “seeks,” “estimates,” “projects,” “may,” “will,” “could,” “might,” or “continues” or similar expressions. The forward-looking statements in this press release include without limitation statements regarding our expectation regarding building shareholder value.  Such statements are based on the beliefs and assumptions of HC2's management and the management of HC2's subsidiaries and portfolio companies. The Company believes these judgments are reasonable, but you should understand that these statements are not guarantees of performance or results, and the Company’s actual results could differ materially from those expressed or implied in the forward-looking statements due to a variety of important factors, both positive and negative, that may be revised or supplemented in subsequent reports on Forms 10-K, 10-Q and 8-K. Such important factors include, without limitation, issues related to the restatement of our financial statements; the fact that we have historically identified material weaknesses in our internal control over financial reporting, and any inability to remediate future material weaknesses; capital market conditions; the ability of HC2's subsidiaries and portfolio companies to generate sufficient net income and cash flows to make upstream cash distributions; volatility in the trading price of HC2 common stock; the ability of HC2 and its subsidiaries and portfolio companies to identify any suitable future acquisition opportunities; our ability to realize efficiencies, cost savings, income and margin improvements, growth, economies of scale and other anticipated benefits of strategic transactions; difficulties related to the integration of financial reporting of acquired or target businesses; difficulties completing pending and future acquisitions and dispositions; effects of litigation, indemnification claims, and other contingent liabilities; changes in regulations and tax laws; and risks that may affect the performance of the operating subsidiaries and portfolio companies of HC2. These risks and other important factors discussed under the caption “Risk Factors” in our most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission (“SEC”), and our other reports filed with the SEC could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release.

You should not place undue reliance on forward-looking statements. All forward-looking statements attributable to HC2 or persons acting on its behalf are expressly qualified in their entirety by the foregoing cautionary statements. All such statements speak only as of the date made, and HC2 undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.


 
HC2 HOLDINGS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts)
(Unaudited)
 
  Three Months Ended June 30, Six Months Ended June 30,
  2017 2016 2017 2016
Services revenue $196,970  $197,372  $432,898  $379,481 
Sales revenue 143,413  125,759  262,027  246,256 
Life, accident and health earned premiums, net 20,235  20,037  40,176  39,971 
Net investment income 16,939  13,707  32,243  27,786 
Net realized gains (losses) on investments 1,095  2,418  1,876  (2,457)
Net revenue 378,652  359,293  769,220  691,037 
Operating expenses        
Cost of revenue - services 189,979  183,193  409,591  358,066 
Cost of revenue - sales 118,685  101,290  213,487  200,967 
Policy benefits, changes in reserves, and commissions 30,443  29,075  61,930  63,095 
Selling, general and administrative 41,707  34,994  81,563  70,591 
Depreciation and amortization 7,295  6,246  14,692  12,201 
Other operating (income) expenses 1,738  (1,499) (1,820) (612)
Total operating expenses 389,847  353,299  779,443  704,308 
   Income (loss) from operations (11,195) 5,994  (10,223) (13,271)
Interest expense (12,073) (10,569) (26,188) (20,895)
Gain (loss) on contingent consideration (88) 192  (319) 192 
Income from equity investees 4,003  6,394  11,696  2,818 
Other (expense), net (3,105) (496) (8,015) (1,210)
Income (loss) from continuing operations before income taxes (22,458) 1,515  (33,049) (32,366)
Income tax (expense) benefit 1,985  (224) (3,306) 2,315 
Net income (loss) (20,473) 1,291  (36,355) (30,051)
Less: Net loss attributable to noncontrolling interest and redeemable noncontrolling interest 2,562  644  3,948  1,524 
Net income (loss) attributable to HC2 Holdings, Inc. (17,911) 1,935  (32,407) (28,527)
Less: Preferred stock and deemed dividends from conversions 793  1,044  1,376  2,113 
Net income (loss) attributable to common stock and participating preferred stockholders $(18,704) $891  $(33,783) $(30,640)
         
Income (loss) per Common Share        
Basic $(0.44) $0.02  $(0.80) $(0.87)
Diluted $(0.44) $0.02  $(0.80) $(0.87)
         
Weighted average common shares outstanding:        
Basic 42,691  35,518  42,322  35,391 
Diluted 42,691  35,643  42,322  35,391 


 
HC2 HOLDINGS, INC.
CONSOLIDATED BALANCE SHEETS
(in thousands, except per share amounts)
(Unaudited)
 
  June 30, December 31,
  2017 2016
Assets    
Investments:    
Fixed maturities, available-for-sale at fair value $1,334,876  $1,278,958 
Equity securities, available-for-sale at fair value 47,810  51,519 
Mortgage loans 21,135  16,831 
Policy loans 18,107  18,247 
Other invested assets 91,381  62,363 
    Total investments 1,513,309  1,427,918 
Cash and cash equivalents 143,130  115,371 
Accounts receivable, net 250,460  267,598 
Recoverable from reinsurers 527,796  524,201 
Deferred tax asset 430  1,108 
Property, plant and equipment, net 282,691  286,458 
Goodwill 97,499  98,086 
Intangibles, net 37,179  39,722 
Other assets 88,816  74,814 
Total assets $2,941,310  $2,835,276 
     
Liabilities, temporary equity and stockholders’ equity    
Life, accident and health reserves $1,682,160  $1,648,565 
Annuity reserves 247,684  251,270 
Value of business acquired 45,385  47,613 
Accounts payable and other current liabilities 258,094  251,733 
Deferred tax liability 15,487  15,304 
Long-term obligations 494,723  428,496 
Other liabilities 97,988  92,871 
Total liabilities 2,841,521  2,735,852 
Commitments and contingencies    
Temporary equity:    
Preferred stock 26,266  29,459 
Redeemable noncontrolling interest 2,373  2,526 
Total temporary equity 28,639  31,985 
Stockholders’ equity    
Common stock, $.001 par value; 43  42 
Shares authorized: 80,000,000 at June 30, 2017 and December 31, 2016;    
Shares issued: 43,365,646 and 42,070,675 at June 30, 2017 and December 31, 2016;    
Shares outstanding: 43,001,167 and 41,811,288 at June 30, 2017 and December 31, 2016, respectively    
Additional paid-in capital 247,167  241,485 
Treasury stock, at cost;  364,479 and 259,387 shares at June 30, 2017 and December 31, 2016, respectively (1,969) (1,387)
Accumulated deficit (206,685) (174,278)
Accumulated other comprehensive income (loss) 12,678  (21,647)
Total HC2 Holdings, Inc. stockholders’ equity 51,234  44,215 
Noncontrolling interest 19,916  23,224 
Total stockholders’ equity 71,150  67,439 
Total liabilities, temporary equity and stockholders’ equity $2,941,310  $2,835,276 


 
HC2 HOLDINGS, INC.
RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED EBITDA
(in thousands)
(Unaudited)
 
  Three Months Ended June 30, 2017
  Core Operating Subsidiaries Early Stage & Other      
  Construction Marine
Services
 Energy Telecom Life
Sciences
 Other and
Eliminations
 Non-
operating
Corporate
 HC2
Net (loss) attributable to HC2 Holdings, Inc.               $(17,911)
Less: Net Income attributable to HC2 Holdings Insurance Segment               164 
Net Income (loss) attributable to HC2 Holdings, Inc., excluding Insurance Segment $4,179  $(3,053) $(365) $2,060  $(4,106) $(3,757) $(13,033) $(18,075)
Adjustments to reconcile net income (loss) to Adjusted EBITDA:                
Depreciation and amortization 1,240  5,255  1,381  94  41  331  16  8,358 
Depreciation and amortization (included in cost of revenue) 1,302              1,302 
Amortization of equity method fair value adjustment at acquisition   (325)           (325)
Asset impairment expense           1,810    1,810 
(Gain) loss on sale or disposal of assets (145)   18          (127)
Lease termination costs   55            55 
Interest expense 174  1,040  154  14    16  10,675  12,073 
Net loss on contingent consideration             88  88 
Other (income) expense, net 28  490  255  (9) (11) 803  214  1,770 
Foreign currency (gain) loss (included in cost of revenue)   83            83 
Income tax (benefit) expense 3,232  (134) (1)       (6,543) (3,446)
Noncontrolling interest 369  (156) (492)   (911) (1,372)   (2,562)
Bonus to be settled in equity             585  585 
Share-based payment expense   394  91    76  18  527  1,106 
Acquisition and nonrecurring items 701            1,168  1,869 
Adjusted EBITDA $11,080  $3,649  $1,041  $2,159  $(4,911) $(2,151) $(6,303) $4,564 
                 
Total Core Operating Subsidiaries $17,929               


 
HC2 HOLDINGS, INC.
RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED EBITDA
(in thousands)
(Unaudited)
 
  Three Months Ended June 30, 2016
  Core Operating Subsidiaries Early Stage & Other      
  Construction Marine
Services
 Energy Telecom Life
Sciences
 Other and
Eliminations
 Non-
operating
Corporate
 HC2
Net Income attributable to HC2 Holdings, Inc.               $1,935 
Less: Net (loss) attributable to HC2 Holdings Insurance Segment               (2,293)
Net Income (loss) attributable to HC2 Holdings, Inc., excluding Insurance Segment $9,364  $6,002  $68  $1,009  $(2,004) $(2,608) $(7,603) $4,228 
Adjustments to reconcile net income (loss) to Adjusted EBITDA:                
Depreciation and amortization 303  6,084  468  140  36  336    7,367 
Depreciation and amortization (included in cost of revenue) (206)             (206)
Amortization of equity method fair value adjustment at acquisition   (359)           (359)
(Gain) loss on sale or disposal of assets (1,845) 7        1    (1,837)
Lease termination costs       338        338 
Interest expense 303  1,285  14      1  8,966  10,569 
Net gain on contingent consideration   (192)           (192)
Other (income) expense, net (32) 403  (344) 29    (10) 465  511 
Foreign currency (gain) loss (included in cost of revenue)   (1,540)           (1,540)
Income tax (benefit) expense 4,524  (212)       1  (9,404) (5,091)
Noncontrolling interest 768  200  244    (812) (1,044)   (644)
Share-based payment expense   152  90    34  40  1,359  1,675 
Acquisition and nonrecurring items       18      313  331 
Adjusted EBITDA $13,179  $11,830  $540  $1,534  $(2,746) $(3,283) $(5,904) $15,150 
                 
Total Core Operating Subsidiaries $27,083               


 
HC2 HOLDINGS, INC.
RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED EBITDA
(in thousands)
(Unaudited)
 
  Six Months Ended June 30, 2017
  Core Operating Subsidiaries Early Stage & Other      
  Construction Marine
Services
 Energy Telecom Life
Sciences
 Other and
Eliminations 
 Non-
operating
Corporate
 HC2
Net (loss) attributable to HC2 Holdings, Inc.               $(32,407)
Less: Net (loss) attributable to HC2 Holdings Insurance Segment               (597)
Net Income (loss) attributable to HC2 Holdings, Inc., excluding Insurance Segment $7,382  $8,099  $(1,062) $3,562  $(7,516) $(9,187) $(33,088) $(31,810)
Adjustments to reconcile net income (loss) to Adjusted EBITDA:                
Depreciation and amortization 2,880  10,340  2,629  191  79  661  33  16,813 
Depreciation and amortization (included in cost of revenue) 2,542              2,542 
Amortization of equity method fair value adjustment at acquisition   (650)           (650)
Asset impairment expense           1,810    1,810 
(Gain) loss on sale or disposal of assets (393) (3,500) 14          (3,879)
Lease termination costs   249            249 
Interest expense 381  2,342  290  23    2,407  20,745  26,188 
Net loss on contingent consideration             319  319 
Other (income) expense, net 7  1,555  1,375  65  (15) 2,918  258  6,163 
Foreign currency (gain) loss (included in cost of revenue)   107            107 
Income tax (benefit) expense 5,311  376  12        (4,366) 1,333 
Noncontrolling interest 632  338  (1,239)   (1,702) (1,977)   (3,948)
Bonus to be settled in equity             585  585 
Share-based payment expense   739  182    168  47  1,489  2,625 
Acquisition and nonrecurring items 946            1,861  2,807 
Adjusted EBITDA $19,688  $19,995  $2,201  $3,841  $(8,986) $(3,321) $(12,164) $21,254 
                 
Total Core Operating Subsidiaries $45,725               


 
HC2 HOLDINGS, INC.
RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED EBITDA
(in thousands)
(Unaudited)
 
  Six Months Ended June 30, 2016
  Core Operating Subsidiaries Early Stage & Other      
  Construction Marine
Services
 Energy Telecom Life
Sciences
 Other and
Eliminations
 Non-
operating
Corporate
 HC2  
Net (loss) attributable to HC2 Holdings, Inc.               $(28,527)
Less: Net (loss) attributable to HC2 Holdings Insurance Segment               (9,789)
Net Income (loss) attributable to HC2 Holdings, Inc., excluding Insurance Segment $13,748  $84  $41  $2,211  $(706) $(13,104) $(21,012) $(18,738)
Adjustments to reconcile net income (loss) to Adjusted EBITDA:                
Depreciation and amortization 832  11,239  897  246  55  672    13,941 
Depreciation and amortization (included in cost of revenue) 1,727              1,727 
Amortization of equity method fair value adjustment at acquisition   (717)           (717)
(Gain) loss on sale or disposal of assets (941) (10)       1    (950)
Lease termination costs       338        338 
Interest expense 613  2,355  23      1  17,903  20,895 
Net gain on contingent consideration   (192)           (192)
Other (income) expense, net (76) 1,015  (375) (996) (3,221) 5,996  (1,146) 1,197 
Foreign currency (gain) loss (included in cost of revenue)   (1,687)           (1,687)
Income tax (benefit) expense 7,969  (852)         (13,630) (6,513)
Noncontrolling interest 829  45  222    (1,532) (1,088)   (1,524)
Share-based payment expense   761  104    56  200  3,745  4,866 
Acquisition and nonrecurring items   266  27  18      2,514  2,825 
Adjusted EBITDA $24,701  $12,307  $939  $1,817  $(5,348) $(7,322) $(11,626) $15,468 
                 
Total Core Operating Subsidiaries $39,764